Keratinocyte apoptosis induced by UV radiation is a major protective mechanism from skin photocarcinogenesis. The induction of apoptosis by UV radiation, as well as a variety of genotoxic stimuli, involves the activation of PKC-d by caspase-3-mediated cleavage in its hinge region, thus generating a constitutively active catalytic fragment. To determine the role of PKC-d cleavage in UV apoptosis signaling, we introduced a caspase-resistant PKC-d mutant (D330A) into human keratinocytes by retrovirus transduction. Overexpression of PKC-d(D330A) protected keratinocytes from UV-induced apoptosis and enhanced long-term survival. PKC-d(D330A) partially prevented the release of cytochrome c from the mitochondria and the loss of Mcl-1, a key antiapoptotic protein downregulated during UV apoptosis. Thus, the cleavage and activation of PKC-d are critical components of UV-induced apoptosis in human keratinocytes, and the inactivation of PKC-d can promote the survival of keratinocytes exposed to UV radiation.
Introduction
Ultraviolet (UV)B radiation from the sun is the primary carcinogen responsible for the formation of nonmelanoma skin cancer, by far the most common type of cancer in the US. Apoptosis is a major tumor suppressor mechanism that eliminates damaged keratinocytes at risk of becoming transformed from the epidermis. UV radiation triggers apoptosis in human keratinocytes by multiple signaling pathways. UV radiation primarily activates the intrinsic or mitochondrial pathway by causing the release of cytochrome c from the mitochondria. 1 Cytochrome c forms a apoptosome complex with Apaf-1 and caspase-9 triggering the activation of caspase-9. In keratinocytes, activated caspase-9 is a critical upstream caspase required for initiating UV apoptosis. 2 However, UV radiation also triggers the clustering and activation of membrane receptors such as Fas and tumor necrosis factor receptor. [3] [4] [5] Caspase-3 is an effector caspase that can be activated by both caspase-8 and caspase-9. Activation of the effector caspases leads to cleavage of numerous cellular proteins that trigger nuclear breakdown, loss of mitochondrial membrane potential, and cell death.
PKC-d is one of over 40 known caspase substrates and is cleaved specifically by caspase-3. 1, 6 This cleavage takes place in the hinge region (V3) of PKC-d at the caspase-3 recognition sequence (DMQD 330 /N). The cleavage of PKC-d is common to the death effector pathways of diverse apoptotic stimuli, including UV radiation, ionizing radiation, DNA-damaging drugs, TNF-a, and anti-Fas antibody. There is a form of PKCd (PKC-d II) which is insensitive to caspase-3, 7 thus cleavage sensitivity can be regulated at the level of RNA splicing. While other PKC isoforms (PKC e, y, z) can undergo proteolysis by caspases, PKC-d was the only isoform activated by this mechanism in keratinocytes during UV radiation-induced apoptosis. 8, 9 PKC-d itself can also initiate apoptosis in keratinocytes involving direct interaction with the mitochondria and alterations of mitochondrial functions. 10, 11 Overexpression of the catalytic domain of PKC-d is sufficient to cause apoptosis in normal keratinocytes, HaCaT cells, HeLa, NIH3T3 and COS1 cells, suggesting that PKC-d is an important effector of apoptosis. 6, 11, 12 Inhibition of PKC activity by the general PKC inhibitor GF109293X partially blocked UV-induced cleavage and activation of PKC-d, pro-caspase-3, and pro-caspase-8, and thus rescued keratinocytes from UV-induced apoptosis, indicating that PKC is involved in a positive feedback loop that amplifies the apoptotic response of keratinocytes to UV. 11, 13 In this study, we examined the mechanism of protection from UV-induced apoptosis in human keratinocytes by selectively blocking the caspase-3-mediated cleavage of PKC-d. Our results demonstrate that inhibition of PKC-d activation by caspase cleavage significantly inhibits apoptosis induced by UV radiation and promotes cell survival. Blocking PKC-d cleavage inhibited the downregulation of Mcl-1 and the release of cytochrome c from the mitochondria, thus preventing the feedback activation of caspases. This indicates that the positive feedback mediated by cleavage-induced activation of PKC-d is required for UV-induced apoptosis in normal human keratinocytes.
resistant to cleavage and activation by caspase-3, we mutated the aspartic acid at 330 to alanine (D330A) as shown schematically in Figure 1a . The full-length wild-type and mutant forms of PKC-d were detectable as a 78-kDa band in Figure 1b . Incubation of cell lysates containing the wild-type PKC-d with active recombinant caspase-3 generated a 43-kDa domain catalytic product. In contrast, the PKC-d(D330A) mutant was not cleaved by recombinant caspase-3. Weak, nonspecific 45 kDa bands were also detected in all lanes.
Activation of PKC-d by UV is blocked by overexpression of PKC-d(D330A)
To determine if the noncleavable PKC-d(D330A) is resistant to activation in cells with caspases activated, we overexpressed PKC-d(D330A) in normal human keratinocytes by retroviral transduction and exposed the cells to UV radiation. As shown in Figure 2 , PKC-d activity was induced over 50-fold 18 h after UV irradiation in vector-infected control cells (Linker), but this induction was inhibited by 64.3% in PKCd(D330A)-expressing cells. Thus, PKC-d(D330A) can act as a dominant inhibitor of PKC-d activation by UV. In contrast, PKC-d(D330A) had no effect on the activation of PKC-d by TPA treatment of cells (Figure 2b ), indicating that PKCd(D330A) selectively inhibited the caspase-3-dependent PKC-d activation.
Normal human keratinocytes are protected from UV-induced apoptosis
Keratinocytes infected with control Linker virus or PKCd(D330A) virus had a typical cobblestone appearance as seen in Figure 3a . When Linker virus-infected keratinocytes underwent UV-induced apoptosis, they became rounded, detached and floated in the media. PKC-d(D330A)-infected keratinocytes were protected from morphological UV-induced cell death as compared to Linker-infected controls, although an approximately 50% decrease in the cell number was observed. This decrease in cell number may be due to a generalized cell cycle arrest induced by UV in the PKCd(D330A)-expressing cells, or may reflect the incomplete protection from apoptosis by PKC-d(D330A), which was also on the order of 50% (Figure 4 ). PKC-d(D330A)-infected keratinocytes had more than 10-fold overexpression of the mutant form of PKC-d as compared to endogenous PKC-d (Figure 3b) .
The survival of keratinocytes exposed to UV was also enhanced by PKC-d(D330A) expression. As shown in Figure 3c , the number of viable cells at 1, 3, and 7 days after UV exposure was higher in the cells expressing PKCd(D300A) than Linker-infected control cells (*Po0.05). While the cells did not proliferate significantly while remaining in the same dish due to apoptotic cellular debris, the keratinocytes did grow after day 3 upon replating into larger dishes. Note that the growth rate of the cells was not increased, but only the overall long-term survival. As a positive control, Bcl-x L infection also enhanced the survival and growth of UVirradiated keratinocytes cells. These results indicate that inhibition of PCK-d cleavage and activation does not simply delay apoptosis, but affords a significant growth advantage.
To determine whether PKC-d(D330A)-infected keratinocytes were protected from apoptosis induced by UV, we performed propidium iodide and Annexin V staining of Figures 4a and b show that in keratinocytes infected with PKC-d(D330A), UVinduced apoptosis was inhibited 62%, as measured by propidium iodide staining from three independent experiments (Po0.05). Annexin V/PI staining was also performed to quantitate early and late apoptotic events. PKC-d(D330A) was able to protect keratinocytes from UV-induced apoptosis as compared to Linker-infected controls. As shown in Figures   4c and d, the protection from UV-induced apoptosis was 68.1% by Annexin V staining from three independent experiments (Po0.05).
PKC-d(D330A) inhibits the release of cytochrome c in response to UV
Cytochrome c release from the mitochondria is an early triggering event in UV apoptosis, while PKC-d cleavage by caspase-3 is a late effector event. As shown in Figure 5 , cytochrome c is elevated B5-fold in the cytoplasmic fraction following UV irradiation, indicating release from the mitochondria. UV-induced cytochrome c release was partially blocked by overexpressing PKC-d(D330A). The inhibition of cytochrome c release by PKC-d(D330A) was reproducible, and an average of four experiments is shown in Figure 5b (n ¼ 4, Po0.05). The release of cytochrome c from mitochondria was also blocked by the antiapoptotic Bcl-x L (data not shown).
PKC-d(D330A) inhibits caspase-3 activity in response to UV
Since the caspase cleavage-resistant PKC-d(D330A) was able to reduce cytochrome c release, we determined the activity of caspase-3 using the fluorogenic substrate Ac-DEVD-AFC and performed Western blots for caspases-3 and cleaved caspase-9 ( Figure 6 ). PKC-d(D330A) significantly inhibited caspase-3 activity (66%) in response to UV exposure. This result was obtained from three independent experiments (Po0.05). PKC-d(D330A) also partially prevented the cleavage of full-length caspase-3 and cleaved caspase-9 in response to UV. In the upper panel of Figure 6b , the full-length form of caspase-3 was detected as a 32-kDa band. In the middle panel of Figure 6b , the cleaved product of caspase-9 was detected as a 17-kDa band. PKC-d(D330A) was able to inhibit caspase-9 cleavage since the level of activated caspase-9 was three-fold less in PKC-d(D330A) than Linker-infected controls. Actin was used as a loading control in the lower panel of Figure 6b . Taken together, these results indicate that PKC-d cleavage is important for amplification of the caspase cascade in the UV-death effector pathway.
PKC-d(D330A) protects keratinocytes from UVinduced loss of mitochondrial membrane potential
To determine whether PKC-d(D330A) was able to protect human keratinocytes from UV-induced loss of mitochondrial membrane potential, we performed Rhodamine 123 staining. The loss of mitochondrial membrane potential is an indicator of cells undergoing the terminal phase of UV-induced apoptosis and is dependent on caspase activity. Figure 7 shows that PKC-d(D330A) protected keratinocytes from UVinduced loss of mitochondrial membrane potential as compared to Linker-infected controls. As shown in Figure 7a virus, and 2 days later exposed to 30 mJ/cm 2 UV. After 1 day, the media was changed and the cells were grown in the same wells until day 3 when they were replated into larger dishes. Viable cell counts were taken on the indicated days after irradiation. The asterisks denote statistically significant different viable cell numbers compared to the Linker control at each time point (n ¼ 2, *Po0.05) with error bars denoting range. Similar results were obtained in an independent experiment of protection was 57.9% as determined by Rhodamine 123 staining from three independent experiments (Po0.05). Thus, PKC-d(D330A) protected normal human keratinocytes from UV-induced loss of mitochondrial membrane potential.
PKC-d(D330A) protects keratinocytes from UV-induced loss of Mcl-1
The UV-induced loss of Mcl-1 is required for release of cytochrome c from mitochondria. To determine if PKC inhibition was able to prevent the downregulation of Mcl-1, keratinocytes were infected with Linker virus, a kinaseinactive PKC-d(K378A) virus, PKC-d(D330A) virus, or treated with the general PKC inhibitor GF109203X. At 18 h after UV exposure, Mcl-1 levels were detected by Western blotting. Figure 8a shows that PKC-d(K378A), PKC-d(D330A), and GF109203X were able to partially protect keratinocytes from UV-induced downregulation of Mcl-1 as compared to Linkerinfected control cells. An extra band was observed at approximately 66 kDa in the PKC-d Western, which could represent a novel cleavage product. However, this band was not reproducible seen elevated in UV-irradiated cell lysates (Figure 9b ). The downregulation of Mcl-1 in keratinocytes in response to UV is partly dependent on caspase activity since zVAD was also able to protect keratinocytes from UV-induced 
Discussion
In human keratinocytes, the induction of apoptosis is a major cellular proofreading mechanism that eliminates damaged cells and protects from skin carcinogenesis. 14, 15 Of the five PKC isoforms expressed in human keratinocytes (a, d, e, Z, z), PKC-d has a clear proapoptotic function 11, 13 as well as an apparent tumor suppressor function since transgenic mice overexpressing PKC-d in the epidermis are resistant to skin tumor promotion by TPA. 16 Activation of overexpressed PKCd, or expression of the enzymatically active catalytic fragment induces apoptosis in keratinocytes. 10, 11 Studies using the pan-PKC inhibitor GF109203X 11, 17 have shown that inhibition of total PKC activity rescues cells from UV-induced apoptosis. In this study, we specifically inhibited the caspase-3-dependent cleavage and activation of PKC-d by overexpressing a cleavage-resistant mutant form of PKC-d. PKC-d(D330A) blocked many UV-induced apoptotic end points including morphological cell death (Figure 3 ), sub-G1 DNA (Figures 4a  and b) , activation of caspase-3 and caspase-9 ( Figure 6 ), and the loss of mitochondrial membrane potential (Figure 7) . PKC-d is a widely expressed PKC isoform that is activated allosterically by TPA or DAG generated from lipid hydrolysis via binding to its C1 domain, or by proteolytic cleavage in its hinge region to generate an active catalytic fragment domain. 6, 11, 18 Translocation of PKC-d from the cytosol to the membrane does not occur in keratinocytes undergoing UV apoptosis; 13 however, rapid translocation has been observed in JB6 cells suggestive of DAG-mediated activation. 19 The PKC-d(D330A) mutant had a functional C1 domain and could be activated by TPA but not caspase-3 (Figure 2 ), indicating that activation of PKC-d by DAG at the C1 domain is not required for UV apoptosis in keratinocytes. The results from this study using the caspase cleavage resistant form of PKC-d indicate that the activation of PKC-d by proteolytic cleavage is the relevant mechanism of activation of PKC-d in keratinocytes undergoing UV apoptosis.
A critical event leading to the activation of PKC-d following UV exposure is the release of cytochrome c from the mitochondria. Inhibition of PKC-d cleavage and activation with PKC-d(D330A) partially inhibited cytochrome c release ( Figure 5 ). The release of cytochrome c following UV exposure is mediated by Bax and Bak, and the early downregulation of the antiapoptotic protein Mcl-1 is also necessary. 20, 21 We found that the downregulation of Mcl-1 by UV was partially prevented by PKC-d(D330A) (Figure 8 ). Mcl-1 itself is a substrate of caspase-3, and some of the protection from Mcl-1 loss is probably due to inhibition of caspase activation by PKC-d(D330A) since zVAD also protected from Mcl-1 loss at later time points. 22 Thus, PKC-d cleavage and activation can feed back to reduce the antiapoptotic protein Mcl-1 involved in initiating cytochrome c. However, because PKC-d cleavage and activation occur after the initial cytochrome c release, protecting from Mcl-1 loss cannot completely block cytochrome c release ( Figure 5 ).
Once cytochrome c is released, it participates in the formation of the apoptosome resulting in activation of the caspase cascade including caspase-3. Active caspase-3 then cleaves PKC-d to generate the active catalytic fragment, which localizes to the mitochondria. However, we showed that the caspase-3 cleavage resistant PKC-d(D330A) inhibits the generation and translocation of the catalytic domain of PKC-d to the mitochondria (Figure 9 ), and this may disrupt the positive feedback loop between the caspase activation and PKC-d. Consistent with this, the PKCd(D330A) mutant was able to partially prevent caspase activation in response to UV (Figure 6 ). Thus, our working model positions PKC-d as a critical caspase-3 substrate, which when cleaved, translocates to the mitochondria to enhance the release of cytochrome c and caspase-9/ caspase-3 activation, thereby promoting apoptosis. The caspase-resistant PKC-d(D330A) inhibits apoptosis by competitively inhibiting endogenous PKC-d cleavage, thus preventing the formation and mitochondrial translocation of the active PKC-d catalytic fragment. We estimate that at least 50% of UV-induced apoptosis requires this PKC-d-positive feedback since we consistently see greater than 50% protection from UV apoptosis when PKC-d cleavage and activation are prevented (Figures 4 and 7) . PKC-d activation is also associated with the loss of mitochondrial membrane potential. This is a late event in UV apoptosis, and PKCd(D330A) was able to protect keratinocytes from UV-induced loss of mitochondrial membrane potential.
Overexpression of PKC-d in the epidermis can suppress skin tumor formation by TPA in mice, 16 and depletion of PKC-d in rat fibroblasts leads to tumor promotion, 27 indicating that PKC-d has a tumor suppressor function. Since activation of overexpressed full-length PKC-d can induce apoptosis, the tumor suppression in PKC-d transgenic mice may be due to the induction of apoptosis. In keratinocytes with ras Ha activated, PKC-d is inhibited by downregulation in human keratinocytes [28] [29] [30] or by tyrosine phosphorylation through Src and Fyn in mouse keratinocytes. 
Materials and Methods

Antibodies and chemicals
For the detection of PKC-d by Western blotting, a carboxyl-terminal PKC-d antibody was used at a dilution of 1 : 4000 (sc-937, Santa Cruz Biotechnology, Santa Cruz, CA, USA). For cytochrome c detection, an antibody (#630105, Clontech, Palo Alto, CA, USA) at 1 : 500 dilution was used. A cleaved caspase-9 antibody (9501S, Cell Signaling, Beverly, MA, USA) and a caspase-3 antibody (sc-7272, Santa Cruz, CA, USA) at 1 : 500 dilution were used. For the detection of Mcl-1, an Mcl-1 antibody was used at a dilution of 1 : 500 (sc-819, Santa Cruz Biotechnology, Santa Cruz, CA, USA). For caspase assays, the fluorogenic substrate Ac-DEVD-AFC for caspase-3 (Enzyme Systems Products, Livermore, CA, USA) was prepared at 20 mM stock in Me 2 SO. The PKC inhibitor GF109203X (Alexis Biochemicals, San Diego, CA, USA) was used at 5 mM.
Cell culture and UV treatment
Normal human epidermal keratinocytes were isolated from neonatal foreskins following routine circumcision as previously described. 13 Each experiment was performed on the cells isolated from a single foreskin and were used at passage 2. Keratinocytes were irradiated with a Panelite Unit (Ultralite Enterprises, Inc., Lawrenceville, GA, USA) equipped with four UVB bulbs (FS36T12/UVB-VHO), which have the majority of their output in the UVB range (B65%), with minor output in the UVA and UVC wavelengths (B34 and B1%, respectively). The cells were exposed with the dish lids removed for the indicated doses, with a 30 mJ/cm 2 dose requiring about 1-min exposure. The UV dose was monitored with an International Light Inc. (Newburyport, MA, USA) radiometer fitted with a UVB detector. For Figure 3b , the growth of cells after UV irradiation was monitored by counting viable cells using Trypan Blue exclusion.
Retrovirus construction, production, and infection
The PKC-d(D330A) mutant containing a mutation of Asp 330 to Ala was generated using the QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla CA, USA). The primers MFD 30: 5 0 -GCT GGG GAG GAT ATG CAA GCC AAC AGT GGG ACC-3 0 and MFD 31: 5 0 -GGT CCC ACT GTT GGC TTG CAT ATC CTC CCC AGC-3 0 were used with the pKS-PKC-d template. 11 The mutated base is underlined. This cleavage resistant mutant form of PKC-d was cloned into LZRS retroviral vector between the EcoR1 and Not1 sites. 31 After cloning, the insert was verified by sequencing and the presence of the mutation confirmed. For retrovirus production, LZRS PKC-d(D330A) DNA was transfected into PhoenixAmpho retroviral packaging cell line using calcium phosphate as described. 32 Packaging cells were selected and expanded in the presence of 1 mg/ml puromycin, and virus was harvested from confluent dishes cultured for 24-48 h at 321C. In some experiments, a kinase-inactive PKCd (K378A) virus was used. For infection, normal keratinocytes were plated in six-well dishes at 10 5 cells per well, and the following day viral supernatant was added in the presence of 4 mg/ml polybrene (hexadimethrine bromide, Sigma). The cells were infected by spinning the plates at 300 Â g for 1 h at 321C, and the viral supernatants replaced with fresh Medium 154. The day after infection, cells were washed two times with phosphate-buffered saline and fed with Medium 154.
Cell fractionation and immunoblotting
Total cell lysates for immunoblotting were prepared by lysing cells in 20 mM Tris-HCl, pH 7.5, 1% Triton X-100, 5 mM EDTA, 40 mg/ml leupeptin, 1 mM pepstatin, 1 mM AEBSF. The lysates were spun in a microcentrifuge for 10 min at 41C, and 20 mg protein from the supernatant was taken for analysis. The proteins were run on SDS polyacrylamide gels, transferred to nitrocellulose, and stained with Ponceau S to ensure protein equal loading. The membranes were blocked with 5% milk in 20 mM Tris-HCl, pH 7.6, 150 mM NaCl (TBS), stained with primary antibody and horseradish peroxidase-conjugated secondary antibody for 1 h each and extensively washed in TBS, 0.05% Tween-20. Proteins were detected using the ECL detection kit (Amersham Life Sciences, Piscataway, NJ, USA).
For cytosol isolation, cells were trypsinized, washed in PBS, and suspended in 10 mM HEPES, pH 7.5, 250 mM sucrose, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EGTA, 1 mM EDTA, 1 mM dithiothreitol, and 1 Â Complete Protease Inhibitor Cocktail (Boehringer Mannheim). Digitonin was added to 0.05%, and the cells were incubated for 2 min at room temperature. The cells were then spun at 750 Â g for 5 min at 41C to pellet unbroken cells and nuclei, and the supernatant was taken and spun at 10 000 Â g at 41C for 25 min. This supernatant was taken as the cytosolic fraction and the pellet was the mitochondrial fraction.
Caspase assay
For caspase assays, cells were trypsinized and combined with floating cells. The cells were lysed in 2 Â caspase-lysis buffer: 25 mM HEPESNaOH, pH 7.4, 10% sucrose, 0.1% CHAPS, 2 mM EDTA, and 5 mM dithothreitol. Cells were spun for 5 min in a microcentrifuge and then the protein concentration was estimated by the Bradford method. Intotal, 50 mg of total protein was used per sample and mixed with 2 Â caspase assay buffer: 25 mM HEPES-NaOH, pH 7.4, 5 mM DTT, and 100 mM of the fluorogenic caspase-3 substrate Ac-DEVD-AFC. After incubation for 18 h at 371C, the fluorimetric detection of cleaved AFC product was performed on CytoFlour Multi-Well Plate Reader Series 4000 (PerSeptive Biosystems) at 400 nM excitation and 530 nM emission filter.
Flow cytometry
Apoptosis was measured by propidium iodide staining and flow cytometry as previously described. 13 Rhodamine 123 staining and flow cytometry to determine loss of mitochondrial membrane potential was performed as previously described. 2 Annexin V staining was performed using an Annexin V-FITC kit (Beckman Coulter Inc., Fullerton, CA, USA). At 18 h after UV exposure, the floaters were combined with the cells obtained after trypsinization and spun for 5 min at 201C. The cell pellets were then washed with ice-cold phosphate-buffered saline with Ca 2 þ and Mg 2 þ . The cell pellets were then suspended in 100 ml of 1 Â diluted binding buffer at 41C. In all, 1 ml of Annexin V and 5 ml of dissolved propidium iodide were then added per sample and incubated at 41C in the dark for 10 min. Ice-cold 1 Â diluted binding buffer (400) was then added per sample tube and mixed gently. The samples were analyzed by flow cytometry immediately after Annexin V staining.
PKC-d immunoprecipitation kinase assay
Keratinocytes were infected with LZRS-Linker virus or LZRS-PKCd(D330A) virus at 20% confluency. When the cells reached 80-90% confluency, they were UV irradiated with a dose of 30 mJ/cm 2 or treated with 2 mM TPA for 15 min. Protein (500 mg) was used per sample for overnight immunoprecipitation with PKC-d (sc-937, Santa Cruz Biotech, CA, USA) and a kinase reaction was performed as previously described. 13 
